| Name | Bepranemab |
|---|
| Description | Bepranemab (UCB 0107) is a humanized, full-length IgG4 monoclonal antibody that binds to a central tau epitope (amino acids 235-250). Bepranemab can be used for Alzheimer’s disease (AD) research[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |